- Jorey Chernett, a 10% owner of Oncology Institute, reported buying 25,000 common shares.
- The reported weighted average purchase price was USD 3.35 per share.
- Following the transaction, Chernett reported beneficial ownership of 10,276,929 common shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193805-26-000306), on March 23, 2026, and is solely responsible for the information contained therein.
Comments